Assessment the Diagnostic Value of Pro-Neurotensin as a Serum Biomarker in MASLD

Not yet recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

August 31, 2025

Conditions
Steatosis of Liver
Interventions
DIAGNOSTIC_TEST

Pro-Neurotensin level as a Serum Biomarker

Pro-Neurotensin mediates the development of fatty liver disease. Neurotensin (NT) is a 13-amino acid peptide secreted by the neuroendocrine cells of the small intestine in response to fat ingestion, which facilitates fatty acid absorption through the gut in relation to food lipid content.

All Listed Sponsors
lead

Sohag University

OTHER

NCT06453239 - Assessment the Diagnostic Value of Pro-Neurotensin as a Serum Biomarker in MASLD | Biotech Hunter | Biotech Hunter